The legacy of Viagra, and its parent company copyright, presents a challenging case study for investors. At first a blockbuster drug, producing billions in sales , its exclusivity period created a deluge of knock-off medications, significantly impacting its dominance. While certain pharmaceutical companies may try to capitalize on male sexual dysfu